Abstract:Graphical and Lay Summary 22(R)‐Hydroxycholesterol (22(R)‐HCHO) is a key precursor of steroids biosynthesis with various biological functions. However, the production of 22(R)‐HCHO is expensive and unsustainable by chemical synthesis and extraction from plants or animals. In this study, the authors demonstrate the efficient biosynthesis of 22(R)‐HCHO in yeast through systematic metabolic engineering, including identification of efficient Dhcr7 and cholesterol 22‐hydroxylase, regulation of key genes expression, and hybrid diploids to balance strain growth and 22(R)‐HCHO production. Finally, the strain 22HC15 produced 2.03 g/L 22(R)‐HCHO in a 5‐L fermenter, which represents the highest 22(R)‐HCHO titer reported to date. The results of this study provide a foundation for further applications of 22(R)‐HCHO in various industrially valuable steroids. 22(R)‐hydroxycholesterol (22(R)‐HCHO) is a crucial precursor of steroids biosynthesis with various biological functions. However, the production of 22(R)‐HCHO is expensive and unsustainable due to chemical synthesis and extraction from plants or animals. This study aimed to construct a microbial cell factory to efficiently produce 22(R)‐HCHO through systems metabolic engineering. First, we tested 7‐dehydrocholesterol reductase (Dhcr7s) and cholesterol C22‐hydroxylases from different sources in Saccharomyces cerevisiae, and the titer of 22(R)‐HCHO reached 128.30 mg L−1 in the engineered strain expressing Dhcr7 from Columba livia (ClDhcr7) and cholesterol 22‐hydroxylase from Veratrum californicum (VcCyp90b27). Subsequently, the 22(R)‐HCHO titer was significantly increased to 427.78 mg L−1 by optimizing the critical genes involved in 22(R)‐HCHO biosynthesis. Furthermore, hybrid diploids were constructed to balance cell growth and 22(R)‐HCHO production and to improve stress tolerance. Finally, the engineered strain produced 2.03 g L−1 of 22(R)‐HCHO in a 5‐L fermenter, representing the highest 22(R)‐HCHO titer reported to date in engineered microbial cell factories. The results of this study provide a foundation for further applications of 22(R)‐HCHO in various industrially valuable steroids.

Combining Metabolic Engineering and Lipid Droplet Assembly to Achieve Campesterol Overproduction in Saccharomyces cerevisiae.

Combinatorial Metabolic Engineering of Saccharomyces Cerevisiae for Improved Production of 7-Dehydrocholesterol

Construction Of A Controllable Beta-Carotene Biosynthetic Pathway By Decentralized Assembly Strategy In Saccharomyces Cerevisiae

Construction of Lycopene-Overproducing Saccharomyces Cerevisiae by Combining Directed Evolution and Metabolic Engineering.

Alleviation of metabolic bottleneck by combinatorial engineering enhanced astaxanthin synthesis in Saccharomyces cerevisiae.

Combined Biosynthetic Pathway Engineering and Storage Pool Expansion for High-Level Production of Ergosterol in Industrial Saccharomyces cerevisiae

Combinatorial Modulation of Linalool Synthase and Farnesyl Diphosphate Synthase for Linalool Overproduction in <i>Saccharomyces cerevisiae</i>

Spatiotemporal Regulation of Astaxanthin Synthesis in S. Cerevisiae.

Sequential control of biosynthetic pathways for balanced utilization of metabolic intermediates in Saccharomyces cerevisiae.

Efficient production of 22(R)‐hydroxycholesterol via combination optimization of Saccharomyces cerevisiae

Improved Linalool Production in Saccharomyces Cerevisiae by Combining Directed Evolution of Linalool Synthase and Overexpression of the Complete Mevalonate Pathway

Dual regulation of lipid droplet-triacylglycerol metabolism and ERG9 expression for improved β-carotene production in Saccharomyces cerevisiae

Alleviation of the Byproducts Formation Enables Highly Efficient Biosynthesis of Rosmarinic Acid in Saccharomyces cerevisiae

Enhanced Astaxanthin Production in S. Cerevisiae by Combinatorial Engineering of Gene Targets Outside the Synthetic Pathway

Construction of a Highly Efficient Synthetic Lycopene Engineered Saccharomyces Cerevisiae

Combining Metabolic Engineering and Lipid Droplet Storage Engineering for Improved α-Bisabolene Production in Yarrowia Lipolytica.

Engineering sub-organelles of a diploid Saccharomyces cerevisiae to enhance the production of 7-dehydrocholesterol

Efficient synthesis of squalene by cytoplasmic-peroxisomal engineering and regulating lipid metabolism in Yarrowia lipolytica

Multi-modular metabolic engineering and efflux engineering for enhanced lycopene production in recombinant Saccharomyces cerevisiae

Reengineering of 7-dehydrocholesterol biosynthesis in Saccharomyces cerevisiae using combined pathway and organelle strategies

Production of β-carotene in Saccharomyces cerevisiae through altering yeast lipid metabolism